Navigation Links
Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
Date:9/4/2012

SAN DIEGO, Sept. 4, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at four investor conferences during the first two weeks of September. These four corporate presentations will be webcast.

Friday, September 7th at 8:30 a.m Eastern Time: NewsMakers in the Biotech Industry Conference in New York City

Monday, September 10th at 11:15 a.m. Eastern Time: Rodman & Renshaw Annual Global Investment Conference in New York City

Wednesday, September 12th at 10:55 a.m. Eastern Time: Morgan Stanley Global Healthcare Conference in New York City

Thursday, September 13th at 1:45 p.m. London Time: Bank of America Merrill Lynch Global Healthcare Conference in London

To listen to the live webcast or a replay of the presentations, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after each event.

Additionally, on Wednesday, September 5th at 4:00 p.m. Eastern Time, Orexigen management will participate in a panel discussion at the Citi 7th Annual Biotech Day event. This event will not be webcast.

About Orexigen Therapeutics Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA.  The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial.  The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Co
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
2. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
3. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
4. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
5. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
6. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
7. Cell Therapeutics, Inc. (CTI) Appoints Former Managing Director, Head of West Coast Biotechnology for Oppenheimer/CIBC Matthew J. Plunkett Executive Vice President, Corporate Development
8. Cell Therapeutics, Inc. Reports Results of Annual Meeting of Shareholders
9. Global Markets for Animal Therapeutics and Diagnostics
10. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
11. Prime Therapeutics named exclusive pharmacy benefit manager for HR Policy Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... N.Y. , Nov. 21, 2014  Cardinal Health, ... world,s largest health care services companies, and Henry Schein, ... provider of health care products and services to office-based ... the companies have entered into a long-term strategic agreement ... product offerings to office-based medical practices.  This strategic agreement ...
(Date:11/21/2014)... MOUNT BRYDGES, Ontario , Nov. 20, 2014 ... workstations, monitor mounting solutions and reading room environment ... implement their newest musculoskeletal radiology reading room, which ... reading room designs at Penn Medicine. ... care by the American College of Radiology,s Imaging ...
(Date:11/21/2014)... , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... the Piper Jaffray 26 th Annual Healthcare Conference in ... the Piper Jaffray conference is scheduled for 8:00 am EST (5:00 ... webcast, and the webcast can be accessed via the Investor Relations ... of the webcast will be archived for 30 days on the ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... and OSAKA, Japan, February 23, 2011 Takeda ... Global Research & Development Center, Inc. U.S., submitted ... Food and Drug Administration (FDA) for an investigational ... for the treatment of hypertension, or high blood ...
... MORRISTOWN, N.J., Feb. 23, 2011 Watson Pharmaceuticals, Inc. ... company, announced today that Paul Bisaro, Watson,s President and ... of the Company,s business at the 2011 Citi Global ... at 1:30 p.m. (EST). The presentation will be webcast ...
Cached Medicine Technology:Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 2Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 3
(Date:11/23/2014)... TX (PRWEB) November 23, 2014 ... market such as its significance, programs and manufacturing ... and Chinese suppliers major market gamers in information. ... information, item specifications, prospective, manufacturing value, and 2009-2014 ... research, the evaluation symbolizes the globally and Chinese ...
(Date:11/23/2014)... Newport Beach, CA (PRWEB) November 23, 2014 ... founder of American Medical Aesthetics & Wellness was ... Dr. Asher Milgrom, Ph.D. is president and CEO of ... Skincare. Dr. Asher Milgrom received a full scholarship ... Sciences and the Medical School at the University of ...
(Date:11/23/2014)... BambooFlooringChina.com , the world’s leader in bamboo flooring, has recently ... collection. Now, the business is announcing big discounts on these ... valid until Dec. 20, 2014. , The new click strand ... which makes it very easy to maintain. As one of ... make its website the best shopping platform for people who ...
(Date:11/22/2014)... PrettyTailor , an outstanding dress company, ... promotion. Customers can buy new dresses at its online ... its website. , As a matter of fact, PrettyTailor ... mainly provides four types of wedding outfits, including bridesmaid ... dresses. It also provides a variety of occasion dresses, ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Today, Dylan ... its new collection of wedding dresses; the business offers ... other related accessories for ladies worldwide, allowing them to ... manager of the company, this new collection of chic ... launch. Moreover, they are offered at discounted rates now. ...
Breaking Medicine News(10 mins):Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 2Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 3Health News:Femoral Stems Industry 2014 Analysis & 2019 Forecasts for Global and Chinese Region in New Research Report at ReportsnReports.com 4Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:Dylan Queen Introduces Its New Wedding Dresses 2
... Findings presented today at the American Society of Clinical ... Clinic oncologist, reveals that a novel application of the ... glioblastoma multiforme. The study was conducted by North Central ... in Rochester, Minn. Eva is the lead investigator of ...
... the Annual Meeting of the American Society of Clinical Oncology ... the groundwork for decisions that included when or if ... ,In patients with metastatic colorectal cancer, counting circulating tumor ... doctors decide when and if a change in course of ...
... interpret confusing situations or those that may possibly be ... Unit of the European Molecular Biology Laboratory (EMBL), ... behaviour in mice. ,Their report, in the ... played by a receptor for the messenger serotonin and ...
... at the receiving end, even if it is all subtle, ... are hard to pin down is more dangerous to mental ... 180 Korean immigrants living in Canada. ,"We found ... on psychological distress such as symptoms of depression and anxiety," ...
... bit relaxed now. Genosis Inc, a US firm, has developed ... test has his and hers components a screening test ... the concentration of motile sperm, and a test for women ... ,The availability of the two-in-one test helps drive ...
... as an option please, a pair of young US researchers ... be after marriage . And never mind the quality of ... Adrianne Frech, a sociology graduate student at Ohio State University, ... a sample of 3,066 men and women who had been ...
Cached Medicine News:Health News:Recurrent Gliomas: Vorinostat Shows Anti-cancer Activity 2Health News:Change in Course of Treatment: Exploring Better Ways 2Health News:Neural Basis of Anxiety: Newer Insights 2Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Fertility Test at Home Possible With a New Kit 2Health News:Marriage Could Lift One Out of Depression, New Study 2
... The ImmunoDOT Borrelia (Lyme) ... (EIA) dot-blot test for the ... Both,species specific (anti-P39) and related ... and IgA) are detected in ...
... are qualitative enzyme immunoassays (EIA) for the ... or IgM, respectively) in serum. Equivocal or ... supplemented with a standardized western blot procedure. ... support a clinical diagnosis of B. burgdorferi ...
... combining microwell EIA and western blot advantages. ... a clinically meaningful cutoff is applied to ... same reagent system used in most western ... Auto 4 detecting the four common extractable ...
... Antibody (IgM) Test is an ... quantitative detection of antibodies to ... is used as an aid ... thrombosis in individuals with systemic ...
Medicine Products: